FABP3 and peripheral arterial disease: Accordingly, recently we identified increased circulating levels of FABP3 in peripheral arterial disease (PAD) patients with severe inflammation and particularly undergoing critical limb ischemia, who were negative for any signs of cardiac damage (18).